HPV
105
32
39
38
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.8%
4 terminated out of 105 trials
90.5%
+3.9% vs benchmark
9%
9 trials in Phase 3/4
24%
9 of 38 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 38 completed trials
Clinical Trials (105)
Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda
The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS2 Kenya
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa
Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL
Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment
Prognostic Biomarkers for Patients With Human Papillomavirus (HPV) Positive Oropharyngeal Squamous Cell Carcinoma
HPV Vaccine Reduced Dose
Assessing Durable Antibody Response to HPV Vaccination
My Self-Sampling for HPV Awareness, Results, and Empowerment
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
mSaada: A Mobile Health Tool
Comparative Self-collection for Cervical Cancer Screening Pivotal Study
PopSci CHW4CervixHealth
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
National Rapid TLC: Testing and Linkage to Care
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer